Wedbush Downgrades NovoCure Ltd. (NVCR) to Neutral

July 26, 2019 7:02 AM EDT
Get Alerts NVCR Hot Sheet
Price: $157.80 -3.78%

Rating Summary:
    6 Buy, 6 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 8
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Wedbush analyst David Nierengarten downgraded NovoCure Ltd. (NASDAQ: NVCR) from Outperform to Neutral with a price target of $80.00 (from $57.00).

For an analyst ratings summary and ratings history on NovoCure Ltd. click here. For more ratings news on NovoCure Ltd. click here.

Shares of NovoCure Ltd. closed at $77.08 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change, Downgrades